Abstract
Introduction: Although respiratory symptoms predominate in the disease caused by the SARS-Cov-2, the new coronavirus, the related neurological implications increase with numbers of new infected, requiring new tools and sufficient medical apparatus to improve the patients’ prognosis. The purpose of this publication is based on the need to clarify the pathophysiological process of COVID-19 from a neurological perspective. The present study aims to review and describe the main neurological aspects associated with SARS-CoV-2, in addition to presenting proposals for conducting and managing these issues.
Methods: The MEDLINE (through PubMed) and Scopus databases were used for systematic research on the correlation between COVID-19 and the nervous system. The reference period were publications between May 2005 and July 2020. The temporal delimitation was based on the objective of elucidating the pathophysiology of neurological involvement seen in the current pandemic. Thus, in 2005, we found articles that reported different etiologies and mechanisms of action of the antiphospholipid syndrome, which helped to understand its current association with COVID-19. Other articles from years prior to the current one contributed, in the same sense of linking, with description of associated processes, in articles from 2020, the SARS-CoV-2 infection. The processes described in times before 2020 and currently correlated with cerebral dysfunction of COVID-19 were distribution of angiotensin II receptors in the brain, inflammation associated with the blood-brain barrier imbalance, and brain barrier function. “SARS-CoV-2 and complications,” “neurology,” “pathogeny of COVID-19,” “stroke,” and “encephalopathy” were terms included in the research. The relevance of the articles found was based on congruence with the search terms and on availability of the full text.
Results: Recent articles published reported mild neurological symptoms, with, for example, headache and anosmia as part of the set of common symptoms of COVID-19, highlighting the causal link between the disease and neurological complications that may exist during its evolution. It is still unknown whether the neurological clinical expression concomitant with the new coronavirus infection is a consequence or a coincidence. In order to properly treat and monitor these patients from the neurological point of view, it is essential, in times of pandemics, to suspect primary infection by SARS-Cov-2 and diagnose it to proceed with isolation and clinical support.
Conclusion: The neurological implications of COVID-19 range from initial symptoms, such as headache, to serious complications, such as ischemic stroke. Although the pathogenesis of neurological phenomena requires further studies, targeted management of the patient is feasible, considering agility in recognizing the infection. Therefore, medical precaution and clinical reasoning are emphasized when providing services to the patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad I, Rathore FA (2020) Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 77:8–12. https://doi.org/10.1016/j.jocn.2020.05.017
Ahmed MU, Hanif M, Ali MJ et al (2020) Neurological manifestations of COVID-19 (SARS-CoV-2): a review. Front Neurol 11:518. https://doi.org/10.3389/fneur.2020.00518
Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413:116832. https://doi.org/10.1016/j.jns.2020.116832
Avula A, Nalleballe K, Narula N et al (2020) COVID-19 presenting as stroke. Brain Behav Immun 87:115–119. https://doi.org/10.1016/j.bbi.2020.04.077
Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host−virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11:995–998. https://doi.org/10.1021/acschemneuro.0c00122
Berger JR (2020) COVID-19 and the nervous system. J Neurovirol 26:143–148. https://doi.org/10.1007/s13365-020-00840-5
Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM (2018) Neurologic alterations due to respiratory virus infections. Front Cell Neurosci 12:386. https://doi.org/10.3389/fncel.2018.00386
Carvalho J, Caleiro M, Vendramini M et al (2010) Clinical and laboratory evaluation of patients with primary antiphospholipid syndrome according to the frequency of antinuclear antibodies (ANA Hep-2). Rev Bras Rheumatol 50(3):262–272
Chen L, Li X, Chen M, Feng Y, Xiong C (2020a) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 116(6):1097–1100. https://doi.org/10.1093/cvr/cvaa078
Chen R, Wang K, Yu J et al (2020b) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. bioRxiv. https://doi.org/10.1101/2020.04.07.030650
Ellul MA, Benjamin L, Singh B et al (2020) Neurological associations of COVID-19. Lancet Neurol 19(9):767–783. https://doi.org/10.1016/S1474-4422(20)30221-0
Fiani B, Covarrubias C, Desai A, Sekhon M, Jarrah R (2020) A contemporary review of neurological sequelae of COVID-19. Front Neurol 11:640. https://doi.org/10.3389/fneur.2020.00640
Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of coronavirus disease (COVID-19). Encephalopathy. Cureus 12(3):e7352. https://doi.org/10.7759/cureus.7352
Giannis D, Ziogas IA, Gianni P (2020) Coagulation disorders in coronavirus infected patients: COVID-19, SARSCoV-1, MERS-CoV and lessons from the past. J Clin Virol 127:104362. https://doi.org/10.1016/j.jcv.2020.104362
Goldberg MF, Goldberg MF, Cerejo R, Tayal AH (2020) Cerebrovascular disease in COVID-19. AJNR Am J Neuroradiol 41(7):1170–1172. https://doi.org/10.3174/ajnr.A6588
Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S et al (2020) Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. https://doi.org/10.1212/WNL.0000000000009619
Jin H, Hong C, Chen S et al (2020) Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol 5:e000382. https://doi.org/10.1136/svn-2020-000382
Kutter JS, Spronken MI, Fraaij PL et al (2018) Transmission routes of respiratory viruses among humans. Curr Opin Virol. 28:142–151. https://doi.org/10.1016/j.coviro.2018.01.001
Li Y, Li M, Wang M et al (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5(3):279–284. https://doi.org/10.1136/svn-2020-000431
Liu X, Zhang R, He G (2020) Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol 99:1421–1428. https://doi.org/10.1007/s00277-020-04103-5
Machado A, Haertel LM (2014) Functional neuroanatomy, 3rd edn. Atheneu
Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):1–9. https://doi.org/10.1001/jamaneurol.2020.1127
Moriguchi T, Harii N, Goto J et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58. https://doi.org/10.1016/j.ijid.2020.03.062
Munhoz RP, Pedroso JL, Nascimento FA et al (2020) Neurological complications in patients with SARS-CoV-2 infection: a systematic review. Arq Neuropsiquiatr 78(5):290–300. https://doi.org/10.1590/0004-282x20200051
Murray E, Tomaszewski M, Guzik TJ (2020) Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications. Cardiovasc Res 116(7):e87–e89. https://doi.org/10.1093/cvr/cvaa096
Nascimento JHP, Gomes BFO, Júnior PRC et al (2020) COVID-19 and hypercoagulable state: a new therapeutic perspective. Arq Bras Cardiol 114(5):829–833. https://doi.org/10.36660/abc.20200308
Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A (2020) Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol 27:1–10. https://doi.org/10.1111/ene.14277
Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264–7275. https://doi.org/10.1128/JVI.00737-08
Paniz-Mondolfi A, Bryce C, Grimes Z et al (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92:699–702. https://doi.org/10.1002/jmv.25915
Rojas H, Ritter C, Dal PF (2011) Mechanisms of dysfunction of the blood-brain barrier in critically ill patients: emphasis on the role of matrix metalloproteinases. Rev Bras Ter Intensiva 23(2):222–227. https://doi.org/10.1590/S0103-507X2011000200016
Romero-Sanchéz CM, Díaz-Maroto I, Fernández-Díaz E et al (2020) Neurologic manifestations in hospitalizes patients with COVID-19: the ALBACOVID. Neurology. https://doi.org/10.1212/WNL.0000000000009937
Santamaria JR, Badziak D, Barros MF et al (2005) Antiphospholipid syndrome. An Bras Dermatol 80(3):225–239
Siddiqi HK, Mehra MR (2020) COVID-19 illness in native and immunosuppressed states: a clinical−therapeutic staging proposal. J Heart Lung Transplant 39(5):405–407. https://doi.org/10.1016/j.healun.2020.03.012
Steardo L, Steardo L Jr, Zorec R, Verkhratsky A (2020) Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) 229(3):e13473. https://doi.org/10.1111/apha.13473
Thachil J, Tang N, Gando S et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18:1023–1026. https://doi.org/10.1111/jth.14810
Tsivgoulis G, Palaiodimou L, Katsanos AH et al (2020) Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord 13:1756286420932036. https://doi.org/10.1177/1756286420932036
Wu Y, Xu X, Chen Z et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18–22. https://doi.org/10.1016/j.bbi.2020.03.031
Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42(11):3323–3328. https://doi.org/10.1161/STROKEAHA.110.608257
Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382(17):e38. https://doi.org/10.1056/NEJMc2007575
Acknowledgments
The Brazilian National Council for Scientific and Technological Development (CNPq) – institution linked to the Brazilian Department of Science, Technology and School of Medicine/Universidade Federal do Cariri (UFCA).
Financing
Brazilian National Council for Scientific and Technological Development (CNPq) – institution linked to the Brazilian Department of Science, Technology and Innovation to encourage research in Brazil.
Conflicts of Interests
All the authors have declared that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Morgado, A.M. et al. (2021). COVID-19’s Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System. In: Asea, A.A.A., Kaur, P. (eds) Coronavirus Therapeutics – Volume II. Advances in Experimental Medicine and Biology, vol 1353. Springer, Cham. https://doi.org/10.1007/978-3-030-85113-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-85113-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-85112-5
Online ISBN: 978-3-030-85113-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)